ArticlePloS one2023

A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study.

Alireza Mohebbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.